About IdentifAI
IdentifAI is a company based in Tel Aviv (Israel) founded in 2020 by Tom Rabinowitz, Amir Beker, Oren Tadmor, Yossi Bornstein, and Noam Shomron. IdentifAI has raised $9.8 million across 3 funding rounds from investors including Shizim, unknown and eHealth Ventures. IdentifAI offers products and services including Prenatal Genetic Screening Test. IdentifAI operates in a competitive market with competitors including Natera, Progenity, SYNLAB, Beikang Medical and Yourgene Health, among others.
- Headquarter Tel Aviv, Israel
- Founders Tom Rabinowitz, Amir Beker, Oren Tadmor, Yossi Bornstein, Noam Shomron
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$9.8 M (USD)
in 3 rounds
-
Latest Funding Round
$6.5 M (USD), Series A
Dec 08, 2024
-
Investors
Shizim
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of IdentifAI
IdentifAI offers a comprehensive portfolio of products and services, including Prenatal Genetic Screening Test.
Non-invasive blood test for early detection of fetal genetic disorders.
Funding Insights of IdentifAI
IdentifAI has successfully raised a total of $9.8M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $6.5 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in IdentifAI
IdentifAI has secured backing from 4 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Shizim, unknown and eHealth Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage digital health ventures are funded and supported.
|
Locked | Locked | Locked | |
|
RS
Ron Sabar |
-
|
Locked | Locked | Locked |
Investor details for IdentifAI
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by IdentifAI
Investment portfolio details for IdentifAI
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - IdentifAI
Detailed financials for IdentifAI
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Identifai Comparisons
Peer comparison for IdentifAI
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of IdentifAI
IdentifAI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natera, Progenity, SYNLAB, Beikang Medical and Yourgene Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Non-invasive prenatal genomic testing is provided for genetic disorders.
|
|
| Locked | Locked | Locked |
Provider of medical diagnosis and clinical laboratory analysis services
|
|
| Locked | Locked | Locked |
NGS-based diagnostic solutions for neonatal screening are developed.
|
|
| Locked | Locked | Locked |
Non-invasive prenatal genetic tests and genomic services are provided.
|
|
| Locked | Locked | Locked |
Noninvasive prenatal testing using cell-free fetal nucleic acids is offered.
|
Detailed competitors of IdentifAI
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Identifai
Complete news archive for IdentifAI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IdentifAI
IdentifAI was founded in 2020 and raised its 1st funding round 3 years after it was founded.
IdentifAI is headquartered in Tel Aviv, Israel.
Amir Beker is the current CEO of IdentifAI. They have also founded this company.
IdentifAI is a funded company, having raised a total of $9.8M across 3 funding rounds to date.
IdentifAI was established in 2020 in Tel Aviv, Israel, within the biotechnology sector. Focus is placed on prenatal diagnostics through a non-invasive test that detects genetic syndromes. Proprietary algorithms in data science and bioinformatics are employed to assess fetal health during early pregnancy stages. Operations center on delivering accessible screening options for expectant parents in the region.
IdentifAI's top competitors include Natera, SYNLAB and Beikang Medical.
IdentifAI offers Prenatal Genetic Screening Test.
IdentifAI has 4 investors. Key investors include Shizim, unknown, eHealth Ventures, and Ron Sabar.